IL116504A - 14, 17-c2-bridged steroids and pharmaceutical compositions containing the same - Google Patents

14, 17-c2-bridged steroids and pharmaceutical compositions containing the same

Info

Publication number
IL116504A
IL116504A IL11650495A IL11650495A IL116504A IL 116504 A IL116504 A IL 116504A IL 11650495 A IL11650495 A IL 11650495A IL 11650495 A IL11650495 A IL 11650495A IL 116504 A IL116504 A IL 116504A
Authority
IL
Israel
Prior art keywords
dione
ethano
methyl
hydrogen
diene
Prior art date
Application number
IL11650495A
Other languages
English (en)
Other versions
IL116504A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL116504A0 publication Critical patent/IL116504A0/xx
Publication of IL116504A publication Critical patent/IL116504A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL11650495A 1994-12-23 1995-12-22 14, 17-c2-bridged steroids and pharmaceutical compositions containing the same IL116504A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide

Publications (2)

Publication Number Publication Date
IL116504A0 IL116504A0 (en) 1996-03-31
IL116504A true IL116504A (en) 2001-11-25

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11650495A IL116504A (en) 1994-12-23 1995-12-22 14, 17-c2-bridged steroids and pharmaceutical compositions containing the same

Country Status (33)

Country Link
US (3) US5827842A (cs)
EP (1) EP0799238B1 (cs)
JP (1) JPH10511379A (cs)
KR (1) KR100400621B1 (cs)
CN (1) CN1109689C (cs)
AR (1) AR002263A1 (cs)
AT (1) ATE193300T1 (cs)
AU (1) AU692346B2 (cs)
BG (1) BG63274B1 (cs)
CA (1) CA2208605C (cs)
CZ (1) CZ292696B6 (cs)
DE (2) DE4447401A1 (cs)
DK (1) DK0799238T3 (cs)
EE (1) EE03356B1 (cs)
ES (1) ES2151612T3 (cs)
FI (1) FI972624A7 (cs)
GR (1) GR3034261T3 (cs)
HU (1) HUP0600457A2 (cs)
IL (1) IL116504A (cs)
LT (1) LT4295B (cs)
LV (1) LV11954B (cs)
NO (1) NO310198B1 (cs)
NZ (1) NZ298770A (cs)
PL (1) PL182642B1 (cs)
PT (1) PT799238E (cs)
RO (1) RO119366B1 (cs)
RU (1) RU2169153C2 (cs)
SI (1) SI9520137A (cs)
SK (1) SK282281B6 (cs)
TW (1) TW333536B (cs)
UA (1) UA45382C2 (cs)
WO (1) WO1996020209A2 (cs)
ZA (1) ZA9510923B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1426352A2 (en) * 1996-09-03 2004-06-09 The Trustees of Columbia University in the City of New York Intermediates for the sythesis of vitamin D and steroid derivatives
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
HRP20040370B1 (hr) * 2001-10-26 2012-09-30 Pop Test Cortisol Llc UPORABA (11ß, 17ß)-11-(1,3-BENZODIOKSOL-5-IL)-17-HIDROKSI-17-(1-PROPINIL)-ESTRA-4,9-DIEN-3-ONA U LIJEČENJU VELIKOG DEPRESIVNOG POREMEĆAJA
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628189A1 (de) 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
US5973172A (en) 1999-10-26
AU4433896A (en) 1996-07-19
ATE193300T1 (de) 2000-06-15
TW333536B (en) 1998-06-11
KR100400621B1 (ko) 2004-02-05
UA45382C2 (uk) 2002-04-15
NO972927L (no) 1997-08-22
AR002263A1 (es) 1998-03-11
LT4295B (lt) 1998-02-25
NO972927D0 (no) 1997-06-23
RO119366B1 (ro) 2004-08-30
CN1171115A (zh) 1998-01-21
IL116504A0 (en) 1996-03-31
DE4447401A1 (de) 1996-07-04
LT97106A (en) 1997-10-27
BG101554A (en) 1998-09-30
CN1109689C (zh) 2003-05-28
US5827842A (en) 1998-10-27
PL182642B1 (pl) 2002-02-28
CZ195497A3 (cs) 1998-03-18
HUP0600457A2 (en) 2006-08-28
LV11954A (lv) 1998-01-20
ZA9510923B (en) 1996-07-04
CZ292696B6 (cs) 2003-11-12
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
FI972624A0 (fi) 1997-06-18
MX9704774A (es) 1997-10-31
DK0799238T3 (da) 2000-10-09
EP0799238B1 (de) 2000-05-24
GR3034261T3 (en) 2000-12-29
ES2151612T3 (es) 2001-01-01
CA2208605C (en) 2008-07-15
WO1996020209A3 (de) 1996-09-06
AU692346B2 (en) 1998-06-04
SK78897A3 (en) 1997-12-10
NO310198B1 (no) 2001-06-05
JPH10511379A (ja) 1998-11-04
NZ298770A (en) 1999-10-28
FI972624A7 (fi) 1997-06-18
BG63274B1 (bg) 2001-08-31
SK282281B6 (sk) 2002-01-07
DE59508403D1 (de) 2000-06-29
US6147065A (en) 2000-11-14
EE03356B1 (et) 2001-02-15
PL320799A1 (en) 1997-10-27
PT799238E (pt) 2000-11-30
EP0799238A2 (de) 1997-10-08
WO1996020209A2 (de) 1996-07-04
LV11954B (lv) 1998-06-20
CA2208605A1 (en) 1996-07-04

Similar Documents

Publication Publication Date Title
AU689642B2 (en) Steroids with a 17-spiromethylene lactone or lactol group
US4701449A (en) Novel 10-substituted steroids and their use in the induction of aldosterone antagonistic activity
US5973172A (en) 14-α,17-α-C2 -bridged norprogesterone derivatives
JP2003515543A (ja) 14,15−ベータ−メチレン置換されたアンドロゲン
AU677019B2 (en) Gestagenically active 19,11-bridged 4-estrenes
US5529993A (en) 14α, 17α-ethano-16α-hydroxy-estratrienes
US6881728B1 (en) 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
US4022892A (en) 17β-Ethynyl-3,17α-estradiol and derivatives thereof
US3983112A (en) 17β-Ethynyl-3,17α-estradiol and derivatives thereof
MXPA97004774A (en) Derivatives of 19-nor-progesterone bridged in c214alfa, 17a
WO1995011915A1 (de) 10,11β-C2-ÜBERBRÜCKTE STEROIDE
DE19535851A1 (de) 18-Norsteroide mit gestagener Wirkung
WO1995027725A1 (de) 11β,19-ÜBERBRÜCKTE 13α-ALKYLSTEROIDE
DE2755578A1 (de) C-homo-oestratriene
FR2594830A1 (fr) Nouveaux 13 epi ou d-homo steroides substitues en position 10b par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees